influenc high-dos aprotinin treatment blood loss coagul pattern patient myocardi revascular intraop administr proteinas inhibitor aprotinin reduct blood loss homolog blood requir patient undergo cardiac surgeri blood-sav effect aprotinin inform mode action patient undergo primari myocardi revascular aprotinin placebo treatment aprotinin bolu kallikrein inactiv unit kiu surgeri continu infus kiu/h surgeri kiu pump prime strict criteria homogen patient select total blood loss ml control group ml aprotinin group homolog blood requir ml ml control group homolog blood blood product aprotinin group twenty-f percent patient control group aprotinin group blood homolog blood product activ clot time indic inhibit contact phase coagul heparin aprotinin group heparin cardiopulmonari bypass cpb 